In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Perspective Therapeutics Inc’s stock clocked out at $3.52, up 2.62% from its previous closing price of $3.43. In other words, the price has increased by $2.62 from its previous closing price. On the day, 1.36 million shares were traded. CATX stock price reached its highest trading level at $3.75 during the session, while it also had its lowest trading level at $3.4.
Ratios:
To gain a deeper understanding of CATX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.60 and its Current Ratio is at 9.60. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 25, 2024, Downgraded its rating to Neutral and sets its target price to $5 from $24 previously.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $20.
On October 01, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $25.Wedbush initiated its Outperform rating on October 01, 2024, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 04 ’24 when HENSON HEIDI bought 25,975 shares for $3.85 per share. The transaction valued at 100,004 led to the insider holds 25,975 shares of the business.
Spoor Johan M. bought 8,000 shares of CATX for $30,132 on Dec 04 ’24. The CEO now owns 36,257 shares after completing the transaction at $3.77 per share. On Nov 25 ’24, another insider, Williamson Robert F III, who serves as the Director of the company, bought 6,266 shares for $3.64 each. As a result, the insider paid 22,814 and bolstered with 430,058 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 237908016 and an Enterprise Value of -25670860. Its current Enterprise Value per Revenue stands at -16.487 whereas that against EBITDA is 0.46.
Stock Price History:
The Beta on a monthly basis for CATX is 1.23, which has changed by -0.3 over the last 52 weeks, in comparison to a change of 0.23171377 over the same period for the S&P500. Over the past 52 weeks, CATX has reached a high of $19.05, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is -26.47%, while the 200-Day Moving Average is calculated to be -69.17%.
Shares Statistics:
It appears that CATX traded 1.56M shares on average per day over the past three months and 1221100 shares per day over the past ten days. A total of 67.56M shares are outstanding, with a floating share count of 48.92M. Insiders hold about 27.62% of the company’s shares, while institutions hold 75.69% stake in the company. Shares short for CATX as of 1735603200 were 8931987 with a Short Ratio of 5.73, compared to 1732838400 on 10445797. Therefore, it implies a Short% of Shares Outstanding of 8931987 and a Short% of Float of 16.08.
Earnings Estimates
A detailed examination of Perspective Therapeutics Inc (CATX) is currently in progress, with 3 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.3 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.8 and -$0.86 for the fiscal current year, implying an average EPS of -$0.84. EPS for the following year is -$1.35, with 3.0 analysts recommending between -$1.04 and -$1.61.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for CATX’s current fiscal year. The highest revenue estimate was $1.61M, while the lowest revenue estimate was $1M, resulting in an average revenue estimate of $1.37M. In the same quarter a year ago, actual revenue was $1.43M
